Royal Bank Of Canada A Tyr Pharma Inc Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in A Tyr Pharma Inc stock. As of the latest transaction made, Royal Bank Of Canada holds 118,998 shares of LIFE stock, worth $221,336. This represents 0.0% of its overall portfolio holdings.

Number of Shares

118,998

Previous 13,850 759.19%

Holding current value

$221,336

Previous $21,000 952.38%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1.51 - $2.24 $158,773 - $235,531	105,148 Added 759.19%	118,998 $221,000
Q2 2024 Aug 14, 2024	SELL	$0.0 - $2.07 $0 - $3,463	-1,673 Reduced 10.78%	13,850 $21,000
Q1 2024 Nov 05, 2024	BUY	$1.42 - $2.02 $2,375 - $3,379	1,673 Added 12.08%	15,523 $30,000
Q1 2024 May 15, 2024	SELL	$1.42 - $2.02 $107,590 - $153,051	-75,768 Reduced 83.0%	15,523 $30,000
Q4 2023 Feb 14, 2024	BUY	$1.11 - $1.51 $11,452 - $15,580	10,318 Added 12.74%	91,291 $128,000
Q3 2023 Nov 14, 2023	SELL	$1.55 - $2.23 $5,356 - $7,706	-3,456 Reduced 4.09%	80,973 $127,000
Q2 2023 Aug 14, 2023	BUY	$1.72 - $2.57 $12,652 - $18,904	7,356 Added 9.54%	84,429 $182,000
Q1 2023 May 15, 2023	BUY	$1.88 - $2.5 $9,973 - $13,262	5,305 Added 7.39%	77,073 $161,000
Q4 2022 Feb 14, 2023	BUY	$2.02 - $2.49 $46,542 - $57,372	23,041 Added 47.29%	71,768 $157,000
Q3 2022 Nov 14, 2022	BUY	$2.79 - $4.15 $134,430 - $199,959	48,183 Added 8857.17%	48,727 $147,000
Q2 2022 Aug 15, 2022	SELL	$2.63 - $5.61 $2,077 - $4,431	-790 Reduced 59.22%	544 $1,000
Q1 2022 May 16, 2022	BUY	$4.75 - $7.54 $3,961 - $6,288	834 Added 166.8%	1,334 $7,000
Q4 2021 Feb 14, 2022	BUY	$7.29 - $9.5 $3,645 - $4,750	500 New	500 $4,000
Q3 2021 Nov 15, 2021	SELL	$4.22 - $12.48 $4 - $12	-1 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$3.62 - $4.88 $3 - $4	1 New	1 $0

Others Institutions Holding LIFE

# of Institutions

Shares Held

37.1M

Call Options Held

30.2K

Put Options Held

3.1K

View Full List

About aTYR PHARMA INC

Ticker LIFE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,625,000
Market Cap $53.2M
Description
aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...

More about LIFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada A Tyr Pharma Inc Transaction History